Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Clinical trial NCT02808104 · COMPLETED
Trial details
- NCT number
- NCT02808104
- Sponsor
- NLS Pharmaceutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-03-28
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.